Literature DB >> 19104517

Cardiac manifestations of HIV infection: an African perspective.

Mpiko Ntsekhe1, Bongani M Mayosi.   

Abstract

The pericardium, myocardium, coronary arteries and pulmonary arteries are the main targets for cardiac disease in people who are infected with HIV. Geography and access to highly active anti-retroviral therapy (HAART) have a major influence on which of these targets is affected. In sub-Saharan Africa, where tuberculosis is endemic and access to HAART is limited, the dominant forms of HIV-associated heart disease are pericardial tuberculosis and cardiomyopathy. However, in industrialized countries, where tuberculosis is rare and HAART is widely available, coronary artery disease is the main cause of death and disability in these patients. Observational data suggest that HAART, by preserving immune function, reduces the incidence of myopericardial disease and pulmonary hypertension. The result has been that, although optimal strategies to reduce vascular disease in this population continue to be sought and debated in industrialized nations, the focus of prevention and treatment strategies for HIV-related heart disease in developing countries has been to support the active campaigns to get universal access to HAART in the first place. Herein, we review the cardiac manifestations of HIV in sub-Saharan Africa.

Entities:  

Mesh:

Year:  2008        PMID: 19104517     DOI: 10.1038/ncpcardio1437

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  74 in total

1.  Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome.

Authors:  D W Anderson; R Virmani; J M Reilly; T O'Leary; R E Cunnion; M Robinowitz; A M Macher; U Punja; S T Villaflor; J E Parrillo
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

Review 2.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa.

Authors:  Bongani M Mayosi
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

Review 3.  A modern approach to tuberculous pericarditis.

Authors:  Faisal F Syed; Bongani M Mayosi
Journal:  Prog Cardiovasc Dis       Date:  2007 Nov-Dec       Impact factor: 8.194

4.  Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

Authors:  Raoul Moh; Christine Danel; Eugène Messou; Timothée Ouassa; Delphine Gabillard; Amani Anzian; Yao Abo; Roger Salamon; Emmanuel Bissagnene; Catherine Seyler; Serge Eholié; Xavier Anglaret
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

Review 5.  HIV-associated pericardial effusions.

Authors:  M J Eisenberg; A S Gordon; N B Schiller
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

Review 6.  Interventions for treating tuberculous pericarditis.

Authors:  B M Mayosi; M Ntsekhe; J A Volmink; P J Commerford
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Myocardial dysfunction in human immunodeficiency virus infection: an echocardiographic study of 157 patients in hospital in Zimbabwe.

Authors:  J G Hakim; J A Matenga; S Siziya
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

8.  Infection of the heart by the human immunodeficiency virus.

Authors:  W W Grody; L Cheng; W Lewis
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

Review 9.  Ischaemic heart disease in Africa.

Authors:  G A Mensah
Journal:  Heart       Date:  2008-07       Impact factor: 5.994

10.  Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania.

Authors:  J P Cegielski; K Ramiya; G J Lallinger; I A Mtulia; I M Mbaga
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

View more
  34 in total

Review 1.  Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.

Authors:  Massimo Imazio; Yehuda Adler
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 2.  Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.

Authors:  Arjun Sinha; Matthew Feinstein
Journal:  Prog Cardiovasc Dis       Date:  2020-01-24       Impact factor: 8.194

Review 3.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

Review 4.  Tuberculous pericarditis with and without HIV.

Authors:  Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

5.  Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective.

Authors:  Sharilyn Almodovar; Stefania Cicalini; Nicola Petrosillo; Sonia C Flores
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

Review 6.  Myocarditis.

Authors:  Sandeep Sagar; Peter P Liu; Leslie T Cooper
Journal:  Lancet       Date:  2011-12-18       Impact factor: 79.321

Review 7.  HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research.

Authors:  Gerald S Bloomfield; Prateeti Khazanie; Alison Morris; Cristina Rabadán-Diehl; Laura A Benjamin; David Murdoch; Virginia S Radcliff; Eric J Velazquez; Charles Hicks
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

8.  Lack of focus on cardiovascular disease in sub-Saharan Africa.

Authors:  Ana Olga Mocumbi
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

Review 9.  Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research.

Authors:  Joshua Remick; Vasiliki Georgiopoulou; Catherine Marti; Igho Ofotokun; Andreas Kalogeropoulos; William Lewis; Javed Butler
Journal:  Circulation       Date:  2014-04-29       Impact factor: 29.690

10.  The mitochondrial DNA T16189C polymorphism and HIV-associated cardiomyopathy: a genotype-phenotype association study.

Authors:  Gasnat Shaboodien; Mark E Engel; Faisal F Syed; Joanna Poulton; Motasim Badri; Bongani M Mayosi
Journal:  BMC Med Genet       Date:  2009-04-27       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.